Stratec (ETR:SBS) PT Set at €66.00 by Warburg Research

Stratec (ETR:SBS) has been given a €66.00 ($76.74) target price by equities research analysts at Warburg Research in a research report issued on Monday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the stock. Warburg Research’s price objective would suggest a potential downside of 5.85% from the stock’s current price.

Separately, Berenberg Bank set a €71.00 ($82.56) price objective on Stratec and gave the company a “buy” rating in a report on Thursday, August 22nd.

Shares of ETR SBS opened at €70.10 ($81.51) on Monday. The stock has a market capitalization of $841.75 million and a PE ratio of 82.96. The company has a debt-to-equity ratio of 55.71, a current ratio of 2.75 and a quick ratio of 1.53. The business has a fifty day moving average price of €71.17 and a two-hundred day moving average price of €63.24. Stratec has a fifty-two week low of €49.00 ($56.98) and a fifty-two week high of €77.60 ($90.23).

About Stratec

Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers.

Further Reading: What are the advantages of the Stochastic Momentum Index?

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.